Stigmasterol attenuates hepatic steatosis in rats by strengthening the intestinal barrier and improving bile acid metabolism

Stigmasterol (ST) has been shown to improve both lipid and bile acid (BA) metabolism. However, the mechanism(s) by which ST prevents dyslipidemia via BA metabolism, and the potential involvement of other regulatory mechanisms, remains unclear. Here, we found that ST treatment effectively alleviates...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yaxin, Gu, Yuyan, Jiang, Jing, Cui, Xiaobing, Cheng, Saibo, Liu, Linling, Huang, Zhiyong, Liao, Rongxin, Zhao, Peng, Yu, Jieying, Wang, Jing, Jia, Yuhua, Jin, Wen, Zhou, Fenghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420112/
https://www.ncbi.nlm.nih.gov/pubmed/36030278
http://dx.doi.org/10.1038/s41538-022-00156-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420112/
https://www.ncbi.nlm.nih.gov/pubmed/36030278
http://dx.doi.org/10.1038/s41538-022-00156-0

Ejemplares similares